3.40Open3.40Pre Close0 Volume1.85K Open Interest12.50Strike Price0.00Turnover112.85%IV11.91%PremiumJul 19, 2024Expiry Date2.17Intrinsic Value100Multiplier6DDays to Expiry1.23Extrinsic Value100Contract SizeAmericanOptions Type-0.8784Delta0.1298Gamma4.59Leverage Ratio-0.0218Theta-0.0016Rho-4.03Eff Leverage0.0028Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet